Direkt zur Hauptnavigation
Direkt zur Suche
Direkt zum Inhalt
Direkt zum Footer
LinkedIn
Contact
Accessibility
Deutsch
Search
Innovation Community
Search
Community
Menu
Close Menu
News and Events
Newsletter
Funding
General Information
Highlight projects
Lighthouses
Clinical Research
Digital Medicine
Aging Medicine
Bio-hybrid Medicine
Gender Medicine
Climate&Health.NRW
Networking
Matchmaking
Innovation community
Topics
Information platform for clinical trials
Clinical trials
Patents and intellectual property rights
Young talents
COVID-19 pandemic
About Medizin.NRW
About us
Our offers
Advisory Board
Our network
Our Strategy
Our Team
Locational advantages NRW
Home
Information platform for clinical trials
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
Share article:
X
LinkedIn
Mail
Copy link
Home
Information platform for clinical trials
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
X
LinkedIn
Mail
Copy link
